Yee, Karen W L <br/><br/>
Phase 1 study of ABT-751, a novel microtubule inhibitor, in patients with refractory hematologic malignancies.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Sep 2005 
 - 6615-24 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-05-0650  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AC133 Antigen<br/>Acute Disease<br/>Adult<br/>Aged<br/>Antigens, CD--analysis<br/>Antineoplastic Agents--adverse effects<br/>CD146 Antigen<br/>Constipation--chemically induced<br/>Diarrhea--chemically induced<br/>Dose-Response Relationship, Drug<br/>Drug Resistance, Neoplasm<br/>Endothelial Cells--chemistry<br/>Female<br/>Glycoproteins--analysis<br/>Hematologic Neoplasms--blood<br/>Humans<br/>Leukemia--blood<br/>Leukocyte Common Antigens--analysis<br/>Male<br/>Microtubules--metabolism<br/>Middle Aged<br/>Mutation<br/>Myelodysplastic Syndromes--blood<br/>Nausea--chemically induced<br/>Neoplasm Recurrence, Local<br/>Neoplastic Cells, Circulating--chemistry<br/>Neural Cell Adhesion Molecules--analysis<br/>Peptides--analysis<br/>Platelet Endothelial Cell Adhesion Molecule-1--analysis<br/>Sulfonamides--adverse effects<br/>Treatment Outcome<br/>Tubulin--genetics<br/>Vomiting--chemically induced